Acetylcysteine Injection
Product Images NDC 0574-0805

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Acetylcysteine (NDC 0574-0805). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Padagis Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Figure 1)

This is a visual aid for medical professionals to evaluate the likelihood of hepatotoxicity occurring based on the concentration of acetaminophen in plasma or serum, measured in ug/mL. There are two lines on the graph; if concentration values fall above the solid line, the likelihood of hepatoxicity is high, and if they fall on or above the broken line, the patient should continue acetylcysteine. The x-axis shows the hours post-ingestion and the y-axis shows the concentration values.*

FDA Label Image

Chemical Structure (Image 01)

FDA Label Image

Image 02

This text is a template for inserting the serial number, lot number, and expiration date of a product.*

FDA Label Image

Image 03

This is a description of Acetylcysteine Injection, available in sterile vials from Perrigo. Each vial contains 6g/30mL (200mg/ml) of the solution, which must be further diluted before intravenous use. The suggested dosage is not provided in the text. The rest of the text consists of unintelligible characters.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.